GAM
AXSM icon

GQ Asset Management’s Axsome Therapeutics AXSM Stock Holding History

GQ Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$56K Buy
+951
New +$77.5K 0.11% 54

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GQ Asset Management's AXSM Position: Q1 2020 in Review

GQ Asset Management opened a new position in Axsome Therapeutics (AXSM) in Q1 2020: 951 shares worth $56K. The stake represents 0.11% of the portfolio and ranks #54 among its holdings.

163 funds tracked by Wall St. Rank hold AXSM as of Q1 2020.

  • GQ Asset Management held 951 shares of Axsome Therapeutics worth $56K as of Q1 2020.
  • Axsome Therapeutics was a new GQ Asset Management position in Q1 2020.
  • Axsome Therapeutics made up 0.11% of GQ Asset Management's portfolio in Q1 2020, its #54 holding.
  • 163 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2020.

Based on GQ Asset Management's 13F filing for Q1 2020, filed 8 May 2020.